LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 111

Search options

  1. Article: Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.

    Schiano Moriello, Aniello / Di Marzo, Vincenzo / Petrosino, Stefania

    Animals : an open access journal from MDPI

    2022  Volume 12, Issue 3

    Abstract: There is growing evidence that perturbation of the gut microbiome, known as "dysbiosis", is associated with the pathogenesis of human and veterinary diseases that are not restricted to the gastrointestinal tract. In this regard, recent studies have ... ...

    Abstract There is growing evidence that perturbation of the gut microbiome, known as "dysbiosis", is associated with the pathogenesis of human and veterinary diseases that are not restricted to the gastrointestinal tract. In this regard, recent studies have demonstrated that dysbiosis is linked to the pathogenesis of central neuroinflammatory disorders, supporting the existence of the so-called microbiome-gut-brain axis. The endocannabinoid system is a recently recognized lipid signaling system and termed endocannabinoidome monitoring a variety of body responses. Accumulating evidence demonstrates that a profound link exists between the gut microbiome and the endocannabinoidome, with mutual interactions controlling intestinal homeostasis, energy metabolism and neuroinflammatory responses during physiological conditions. In the present review, we summarize the latest data on the microbiome-endocannabinoidome mutual link in health and disease, focalizing the attention on gut dysbiosis and/or altered endocannabinoidome tone that may distort the bidirectional crosstalk between these two complex systems, thus leading to gastrointestinal and metabolic diseases (e.g., idiopathic inflammation, chronic enteropathies and obesity) as well as neuroinflammatory disorders (e.g., neuropathic pain and depression). We also briefly discuss the novel possible dietary interventions based not only on probiotics and/or prebiotics, but also, and most importantly, on endocannabinoid-like modulators (e.g., palmitoylethanolamide) for intestinal health and beyond.
    Language English
    Publishing date 2022-01-31
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2606558-7
    ISSN 2076-2615
    ISSN 2076-2615
    DOI 10.3390/ani12030348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.

    Petrosino, Stefania / Schiano Moriello, Aniello

    International journal of molecular sciences

    2020  Volume 21, Issue 24

    Abstract: Neuroinflammation is a physiological response aimed at maintaining the homodynamic balance and providing the body with the fundamental resource of adaptation to endogenous and exogenous stimuli. Although the response is initiated with protective purposes, ...

    Abstract Neuroinflammation is a physiological response aimed at maintaining the homodynamic balance and providing the body with the fundamental resource of adaptation to endogenous and exogenous stimuli. Although the response is initiated with protective purposes, the effect may be detrimental when not regulated. The physiological control of neuroinflammation is mainly achieved via regulatory mechanisms performed by particular cells of the immune system intimately associated with or within the nervous system and named "non-neuronal cells." In particular, mast cells (within the central nervous system and in the periphery) and microglia (at spinal and supraspinal level) are involved in this control, through a close functional relationship between them and neurons (either centrally, spinal, or peripherally located). Accordingly, neuroinflammation becomes a worsening factor in many disorders whenever the non-neuronal cell supervision is inadequate. It has been shown that the regulation of non-neuronal cells-and therefore the control of neuroinflammation-depends on the local "
    MeSH term(s) Alzheimer Disease/diet therapy ; Alzheimer Disease/drug therapy ; Alzheimer Disease/metabolism ; Amides/administration & dosage ; Amides/metabolism ; Amyotrophic Lateral Sclerosis/diet therapy ; Amyotrophic Lateral Sclerosis/drug therapy ; Amyotrophic Lateral Sclerosis/metabolism ; Animals ; Autism Spectrum Disorder/diet therapy ; Autism Spectrum Disorder/drug therapy ; Autism Spectrum Disorder/metabolism ; Endocannabinoids/metabolism ; Ethanolamines/administration & dosage ; Ethanolamines/metabolism ; Humans ; Inflammation/diet therapy ; Inflammation/drug therapy ; Inflammation/metabolism ; Metabolic Networks and Pathways ; Multiple Sclerosis/diet therapy ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/metabolism ; Nervous System Diseases/diet therapy ; Nervous System Diseases/drug therapy ; Nervous System Diseases/metabolism ; Neurodegenerative Diseases/diet therapy ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/metabolism ; Pain/diet therapy ; Pain/drug therapy ; Palmitic Acids/administration & dosage ; Palmitic Acids/metabolism ; Parkinson Disease/drug therapy ; Parkinson Disease/metabolism
    Chemical Substances Amides ; Endocannabinoids ; Ethanolamines ; Palmitic Acids ; palmidrol (6R8T1UDM3V)
    Language English
    Publishing date 2020-12-15
    Publishing country Switzerland
    Document type Journal Article ; Systematic Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21249526
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint

    Schiano Moriello, Aniello / Di Marzo, Vincenzo / Petrosino, Stefania

    Animals. 2022 Jan. 31, v. 12, no. 3

    2022  

    Abstract: There is growing evidence that perturbation of the gut microbiome, known as “dysbiosis”, is associated with the pathogenesis of human and veterinary diseases that are not restricted to the gastrointestinal tract. In this regard, recent studies have ... ...

    Abstract There is growing evidence that perturbation of the gut microbiome, known as “dysbiosis”, is associated with the pathogenesis of human and veterinary diseases that are not restricted to the gastrointestinal tract. In this regard, recent studies have demonstrated that dysbiosis is linked to the pathogenesis of central neuroinflammatory disorders, supporting the existence of the so-called microbiome-gut-brain axis. The endocannabinoid system is a recently recognized lipid signaling system and termed endocannabinoidome monitoring a variety of body responses. Accumulating evidence demonstrates that a profound link exists between the gut microbiome and the endocannabinoidome, with mutual interactions controlling intestinal homeostasis, energy metabolism and neuroinflammatory responses during physiological conditions. In the present review, we summarize the latest data on the microbiome-endocannabinoidome mutual link in health and disease, focalizing the attention on gut dysbiosis and/or altered endocannabinoidome tone that may distort the bidirectional crosstalk between these two complex systems, thus leading to gastrointestinal and metabolic diseases (e.g., idiopathic inflammation, chronic enteropathies and obesity) as well as neuroinflammatory disorders (e.g., neuropathic pain and depression). We also briefly discuss the novel possible dietary interventions based not only on probiotics and/or prebiotics, but also, and most importantly, on endocannabinoid-like modulators (e.g., palmitoylethanolamide) for intestinal health and beyond.
    Keywords cannabinoids ; digestive tract ; dysbiosis ; energy metabolism ; homeostasis ; humans ; inflammation ; intestinal microorganisms ; intestines ; lipids ; obesity ; pain ; pathogenesis ; prebiotics ; probiotics
    Language English
    Dates of publication 2022-0131
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2606558-7
    ISSN 2076-2615
    ISSN 2076-2615
    DOI 10.3390/ani12030348
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

    Petrosino, Stefania / Di Marzo, Vincenzo

    British journal of pharmacology

    2016  Volume 174, Issue 11, Page(s) 1349–1365

    Abstract: Palmitoylethanolamide (PEA) has emerged as a potential nutraceutical, because this compound is naturally produced in many plant and animal food sources, as well as in cells and tissues of mammals, and endowed with important neuroprotective, anti- ... ...

    Abstract Palmitoylethanolamide (PEA) has emerged as a potential nutraceutical, because this compound is naturally produced in many plant and animal food sources, as well as in cells and tissues of mammals, and endowed with important neuroprotective, anti-inflammatory and analgesic actions. Several efforts have been made to identify the molecular mechanism of action of PEA and explain its multiple effects both in the central and the peripheral nervous system. Here, we provide an overview of the pharmacology, efficacy and safety of PEA in neurodegenerative disorders, pain perception and inflammatory diseases. The current knowledge of new formulations of PEA with smaller particle size (i.e. micronized and ultra-micronized) when given alone or in combination with antioxidant flavonoids (i.e. luteolin) and stilbenes (i.e. polydatin) is also reviewed.
    Linked articles: This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc.
    MeSH term(s) Amides ; Analgesics/administration & dosage ; Analgesics/adverse effects ; Analgesics/pharmacology ; Animals ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/pharmacology ; Chemistry, Pharmaceutical/methods ; Dietary Supplements ; Ethanolamines/administration & dosage ; Ethanolamines/adverse effects ; Ethanolamines/pharmacology ; Humans ; Inflammation/diet therapy ; Neurodegenerative Diseases/diet therapy ; Neuroprotective Agents/administration & dosage ; Neuroprotective Agents/adverse effects ; Neuroprotective Agents/pharmacology ; Palmitic Acids/administration & dosage ; Palmitic Acids/adverse effects ; Palmitic Acids/pharmacology ; Particle Size
    Chemical Substances Amides ; Analgesics ; Anti-Inflammatory Agents ; Ethanolamines ; Neuroprotective Agents ; Palmitic Acids ; palmidrol (6R8T1UDM3V)
    Language English
    Publishing date 2016-09-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80081-8
    ISSN 1476-5381 ; 0007-1188
    ISSN (online) 1476-5381
    ISSN 0007-1188
    DOI 10.1111/bph.13580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

    Iannotti, Fabio Arturo / Di Marzo, Vincenzo / Petrosino, Stefania

    Progress in lipid research

    2016  Volume 62, Page(s) 107–128

    Abstract: The endocannabinoid system (ECS) is composed of two G protein-coupled receptors (GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid ligands of such receptors (also known as the "endocannabinoids"), anandamide and 2- ... ...

    Abstract The endocannabinoid system (ECS) is composed of two G protein-coupled receptors (GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid ligands of such receptors (also known as the "endocannabinoids"), anandamide and 2-arachidonoyl-glycerol. The ECS is a pleiotropic signalling system involved in all aspects of mammalian physiology and pathology, and for this reason it represents a potential target for the design and development of new therapeutic drugs. However, the endocannabinoids as well as some of their congeners also interact with a much wider range of receptors, including members of the Transient Receptor Potential (TRP) channels, Peroxisome Proliferator-Activated Receptors (PPARs), and other GPCRs. Indeed, following the discovery of the endocannabinoids, endocannabinoid-related lipid mediators, which often share the same metabolic pathways of the endocannabinoids, have also been identified or rediscovered. In this review article, we discuss the role of endocannabinoids and related lipids during physiological functions, as well as their involvement in some of the most common neurological disorders.
    MeSH term(s) Animals ; Arachidonic Acids/metabolism ; Endocannabinoids/biosynthesis ; Endocannabinoids/metabolism ; Glycerides/metabolism ; Humans ; Lipid Metabolism ; Metabolic Networks and Pathways ; Peroxisome Proliferator-Activated Receptors/metabolism ; Polyunsaturated Alkamides/metabolism ; Receptors, Cannabinoid/metabolism ; Receptors, G-Protein-Coupled/metabolism ; Transient Receptor Potential Channels/metabolism
    Chemical Substances Arachidonic Acids ; Endocannabinoids ; Glycerides ; Peroxisome Proliferator-Activated Receptors ; Polyunsaturated Alkamides ; Receptors, Cannabinoid ; Receptors, G-Protein-Coupled ; Transient Receptor Potential Channels ; glyceryl 2-arachidonate (8D239QDW64) ; anandamide (UR5G69TJKH)
    Language English
    Publishing date 2016
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 282560-0
    ISSN 1873-2194 ; 0079-6832 ; 0163-7827
    ISSN (online) 1873-2194
    ISSN 0079-6832 ; 0163-7827
    DOI 10.1016/j.plipres.2016.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury.

    Schiano Moriello, Aniello / Roviezzo, Fiorentina / Iannotti, Fabio Arturo / Rea, Giuseppina / Allarà, Marco / Camerlingo, Rosa / Verde, Roberta / Di Marzo, Vincenzo / Petrosino, Stefania

    Biomolecules

    2022  Volume 13, Issue 1

    Abstract: Acute respiratory distress syndrome (ARDS) is a serious inflammatory lung disorder and a complication of SARS-CoV-2 infection. In patients with severe SARS-CoV-2 infection, the transition to ARDS is principally due to the occurrence of a cytokine storm ... ...

    Abstract Acute respiratory distress syndrome (ARDS) is a serious inflammatory lung disorder and a complication of SARS-CoV-2 infection. In patients with severe SARS-CoV-2 infection, the transition to ARDS is principally due to the occurrence of a cytokine storm and an exacerbated inflammatory response. The effectiveness of ultra-micronized palmitoylethanolamide (PEA-um) during the earliest stage of COVID-19 has already been suggested. In this study, we evaluated its protective effects as well as the effectiveness of its congener, 2-pentadecyl-2-oxazoline (PEA-OXA), using in vitro models of acute lung injury. In detail, human lung epithelial cells (A549) activated by polyinosinic-polycytidylic acid (poly-(I:C)) or Transforming Growth Factor-beta (TGF-β) were treated with PEA-OXA or PEA. The release of IL-6 and the appearance of Epithelial-Mesenchymal Transition (EMT) were measured by ELISA and immunofluorescence assays, respectively. A possible mechanism of action for PEA-OXA and PEA was also investigated. Our results showed that both PEA-OXA and PEA were able to counteract poly-(I:C)-induced IL-6 release, as well as to revert TGF-β-induced EMT. In addition, PEA was able to produce an "entourage" effect on the levels of the two endocannabinoids AEA and 2-AG, while PEA-OXA only increased PEA endogenous levels, in poly-(I:C)-stimulated A549 cells. These results evidence for the first time the superiority of PEA-OXA over PEA in exerting protective effects and point to PEA-OXA as a new promising candidate in the management of acute lung injury.
    MeSH term(s) Humans ; Interleukin-6 ; COVID-19 ; SARS-CoV-2 ; Transforming Growth Factor beta ; Acute Lung Injury/drug therapy
    Chemical Substances 2-pentadecyl-2-oxazoline ; Interleukin-6 ; Transforming Growth Factor beta
    Language English
    Publishing date 2022-12-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom13010033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

    Petrosino, Stefania / Verde, Roberta / Vaia, Massimo / Allarà, Marco / Iuvone, Teresa / Di Marzo, Vincenzo

    The Journal of pharmacology and experimental therapeutics

    2018  Volume 365, Issue 3, Page(s) 652–663

    Abstract: Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2 ( ... ...

    Abstract Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2 (CB
    MeSH term(s) Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Arachidonic Acids/metabolism ; Cannabidiol/pharmacology ; Cannabidiol/therapeutic use ; Cell Line ; Chemokine CCL8/metabolism ; Dermatitis, Allergic Contact/drug therapy ; Dermatitis, Allergic Contact/metabolism ; Endocannabinoids/metabolism ; Humans ; Interleukin-6/metabolism ; Interleukin-8/metabolism ; Polyunsaturated Alkamides/metabolism ; Tumor Necrosis Factor-alpha/metabolism
    Chemical Substances Anti-Inflammatory Agents ; Arachidonic Acids ; CCL8 protein, human ; Chemokine CCL8 ; Endocannabinoids ; Interleukin-6 ; Interleukin-8 ; Polyunsaturated Alkamides ; Tumor Necrosis Factor-alpha ; Cannabidiol (19GBJ60SN5) ; anandamide (UR5G69TJKH)
    Language English
    Publishing date 2018-04-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3106-9
    ISSN 1521-0103 ; 0022-3565
    ISSN (online) 1521-0103
    ISSN 0022-3565
    DOI 10.1124/jpet.117.244368
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.

    Petrosino, Stefania / Di Marzo, Vincenzo

    Current opinion in investigational drugs (London, England : 2000)

    2010  Volume 11, Issue 1, Page(s) 51–62

    Abstract: Apart from their widespread recreational abuse, the psychoactive preparations of the plant Cannabis sativa and its major psychotropic component, Delta9-tetrahydrocannabinol (THC), are also known for their medicinal properties. Following the ... ...

    Abstract Apart from their widespread recreational abuse, the psychoactive preparations of the plant Cannabis sativa and its major psychotropic component, Delta9-tetrahydrocannabinol (THC), are also known for their medicinal properties. Following the identification of receptors for THC - the cannabinoid CB1 and CB2 receptors - in mammals, various pharmaceutical strategies have attempted to exploit the properties of the cannabinoid system while minimizing psychotropic side effects. The cloning of the cannabinoid CB1 and CB2 receptors enabled the discovery of the endogenous agonists of the receptors, the endocannabinoids, and eventually led to the identification of enzymes that catalyze endocannabinoid inactivation. Unlike exogenously administered THC and synthetic CB1 and CB2 agonists, the endocannabinoids that are produced endogenously following the onset of several pathologies may act in a site- and time-specific manner to minimize the consequences of such conditions. This observation has suggested the possibility of targeting endocannabinoid-degrading enzymes to prolong the precisely regulated pro-homeostatic action of endocannabinoids. Two major enzymes have been cloned and investigated thoroughly: fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Inhibitors of these enzymes have demonstrated therapeutic benefit in animal models of several disorders, including neuropathic pain, anxiety and inflammatory bowel diseases, as well as against the proliferation and migration of cancer cells. This review describes the major biochemical properties of FAAH and MAGL, and the design and pharmacological properties of inhibitors of these enzymes.
    MeSH term(s) Amidohydrolases/antagonists & inhibitors ; Animals ; Cannabinoid Receptor Modulators/metabolism ; Endocannabinoids ; Enzyme Inhibitors/pharmacology ; Humans ; Monoacylglycerol Lipases/antagonists & inhibitors ; Psychotropic Drugs/pharmacology ; Receptor, Cannabinoid, CB1/drug effects ; Receptor, Cannabinoid, CB2/drug effects ; Structure-Activity Relationship
    Chemical Substances Cannabinoid Receptor Modulators ; Endocannabinoids ; Enzyme Inhibitors ; Psychotropic Drugs ; Receptor, Cannabinoid, CB1 ; Receptor, Cannabinoid, CB2 ; Monoacylglycerol Lipases (EC 3.1.1.23) ; Amidohydrolases (EC 3.5.-) ; fatty-acid amide hydrolase (EC 3.5.1.-)
    Language English
    Publishing date 2010-01
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2027913-9
    ISSN 2040-3429 ; 0967-8298 ; 1472-4472
    ISSN (online) 2040-3429
    ISSN 0967-8298 ; 1472-4472
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Conference proceedings: N-Acylethanolamine acid amidase (NAAA) inhibition rescues intestinal fibrosis through IL-23 pathway

    Nanì, MariaFrancesca / Lucariello, Giuseppe / Pagano, Ester / Cattaneo, Fabio / Cicia, Donatella / Raucci, Federica / Tropeano, FrancescaPaola / Petrosino, Stefania / Cicco, PaolaDe / Borrelli, Francesca / Izzo, AngeloA. / Romano, Barbara

    Zeitschrift für Gastroenterologie

    2023  Volume 61, Issue 03

    Event/congress 50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V., Erlangen, 2023-04-21
    Language German
    Publishing date 2023-03-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/s-0043-1764100
    Database Thieme publisher's database

    More links

    Kategorien

  10. Article ; Conference proceedings: N-Acylethanolamine acid amidase (NAAA) inhibition rescues intestinal fibrosis through IL-23 pathway

    Nanì, MariaFrancesca / Lucariello, Giuseppe / Pagano, Ester / Cattaneo, Fabio / Cicia, Donatella / Raucci, Federica / Tropeano, FrancescaPaola / Petrosino, Stefania / Cicco, PaolaDe / Borrelli, Francesca / Izzo, AngeloA. / Romano, Barbara

    Zeitschrift für Gastroenterologie

    2023  Volume 61, Issue 03

    Event/congress 50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V., Erlangen, 2023-04-21
    Language German
    Publishing date 2023-03-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/s-0043-1764094
    Database Thieme publisher's database

    More links

    Kategorien

To top